Lifecore Biomedical, Inc. Financials

LFCR

All currency values in $ millions unless otherwise noted

Scroll

Showing 5 of 26 available years

Income Statement	DEC 2025	MAY 2025	MAY 2024	MAY 2023	FEB 2023
Revenues
Revenue	–	$129	$128	$103	–
Cost of Revenue	–	$89	$86	$75	–
Gross Profit	–	$40	$42	$28	–
General & Administrative	–	$44	$40	$39	–
Research & Development	–	$8	$9	$9	–
Provision for Doubtful Accounts	–	$1	$0	$0	–
Total Operating Expenses	–	$146	$51	$50	–
Operating Income	–	-$17	-$9	-$22	–
Non-Operating
Net Interest Expense	–	-$22	-$18	-$18	–
Other Non-Operating Income (Expense)	–	$0	$36	-$25	–
EBT (Earnings Before Tax)	–	-$39	$10	-$64	–
Income Tax Expense	–	$0	$0	$0	–
Earnings from Continuing Ops	–	-$39	$9	-$64	–
Net Income
Net Income	–	-$39	$12	-$100	–
Per Share Data
Revenue Per Share	–	$3.70	$3.50	$3.44	–
EPS (Basic)	–	-$1.27	$0.39	-$3.32	–
EPS (Diluted)	–	-$1.27	$0.33	-$3.32	–
Weighted Avg Shares (Basic)	37.4M	34.8M	30.5M	30.0M	30.3M
Weighted Avg Shares (Diluted)	37.4M	34.8M	36.7M	30.0M	29.8M
Shares Outstanding	37.4M	34.8M	36.7M	30.0M	29.8M

SourceFinancial statements computed from the 10-Q filed 29 Jul 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 12 Oct 2026. How this is calculated.

Fiscal year ends May.

Peers

Pharmaceutical Preparations · Pick stocks to compare with LFCR

CompareIntrinsic value

ASRTAssertio Holdings Inc.

$9.09+0.28%10

TBPHTheravance Biopharma Inc.

No recent price82

XNCRXencor Inc.

$35.01+14.28%0

ETONEton Pharmaceuticals Inc.

$50.72-0.45%75

SEPNSepterna, Inc.

$47.88+9.57%46

AGIOAgios Pharmaceuticals Inc.

$31.38+0.58%40

GYREGyre Therapeutics Inc.

$4.44+0.00%18

SPRYArs Pharmaceuticals Inc

$3.05+0.00%40

Held by ETFs

LFCR is in 5 US ETFs. The largest of them, with LFCR's weight in each:

Spot a number that looks wrong? Check it in LFCR's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing LFCR

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.